Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 7 novembre 2019
Doi : 10.1016/j.jaad.2019.05.092
Psoriasis prevalence in the United States in a commercial insurance claims database: 2011-2017
 

Jeffrey M. Cohen, MD, Priscilla W. Wong, MS, David E. Cohen, MD, MPH, Randie H. Kim, MD, PhD
 Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York 

Correspondence to: Randie H. Kim, MD, PhD, The Ronald O. Perelman Department of Dermatology, NYU School of Medicine, 240 E 38th St, 11th Floor, New York, NY 10016.The Ronald O. Perelman Department of DermatologyNYU School of Medicine240 E 38th St, 11th FloorNew YorkNY10016

Abbreviation used : CI



 Funding sources: None.
 Disclosure: Dr D. Cohen has been a consultant for and received honoraria from Dermavent, Ferndale Laboratories, Medimetriks, Cutanea, Ferrer, Celgene, and FIDE (FIDE receives industry sponsorship from AbbVie, Almirall, Bausch and Lomb, Bristol Myers, Celgene, Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Sun Pharma, UCB, and Valeant); has stock or stock options with Dermira, Medimetriks, Brickell Biotech, and Kadmon; and serves on the board of directors of Dermira and Kadmon. Dr J. Cohen, Ms Wong, and Dr Kim have no conflicts of interest to declare.
 Reprints not available from the authors.


Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@